Skip to Content
Merck
CN

The role of antimicrobials in Crohn's disease.

Expert review of gastroenterology & hepatology (2013-03-01)
Pramodini B Kale-Pradhan, Jing J Zhao, Jennifer R Palmer, Sheila M Wilhelm
ABSTRACT

This review summarizes literature regarding the role of antimicrobials for induction and maintenance of Crohn's disease (CD) remission. PubMed was searched (1966 to October 2012) for controlled trials involving adults and written in English. Five of the 13 identified studies showed benefit with the use of ciprofloxacin, metronidazole and rifaximin for induction of remission. Eight studies showed no benefit using ciprofloxacin, metronidazole, combination of metronidazole and ciprofloxacin or clarithromycin and rifaximin. Four of the five studies showed benefit based on colonic location. Perianal CD with draining fistulas responded in one of two studies. Two studies in postileocolonic resection demonstrated benefit of metronidazole or ornidazole in reducing CD recurrence. Antimicrobials, especially metronidazole, are promising for inducing remission in patients with colonic CD and preventing recurrence in postileocolonic resection.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Clarithromycin, 96.0-102.0% (HPLC)
Sigma-Aldrich
Rifaximin
Supelco
Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Rifaximin, VETRANAL®, analytical standard
Supelco
Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Clarithromycin, ≥95% (HPLC)
Clarithromycin, European Pharmacopoeia (EP) Reference Standard
Supelco
Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metronidazole, VETRANAL®, analytical standard
Supelco
Metronidazole, analytical standard
Sigma-Aldrich
Metronidazole, BioXtra
Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Supelco
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Ciprofloxacin hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard